Special Issue "The Prevention and Treatment of Atherosclerosis"
Deadline for manuscript submissions: 31 December 2021.
Interests: Cardiovascular disease; Inflammatory cytokines and microRNAs in atherosclerosis and aortic valve stenosis; Atherosclerosis prevention and treatment; Interventions on carotid and renal arteries; Renovascular disease; Monitoring of atherosclerosis progression; Carotid intima-media; Arterial stiffness; Vascular age
This special issue of Journal of Clinical Medicine ‘The Prevention and Treatment of Atherosclerosis’ will walk the Readers across novel diagnostic achievements in atherosclerosis and contemporary actions towards optimizing therapy.
Everything begins with diagnosis. Correct and timely, optimally providing additional information on the risk associated with findings, diagnosis enables introduction of prevention and cure. Thus, accurate diagnostic tools and tests are of utmost importance. Contemporary research on microparticles, non-coding RNAs, proteomic characterization, …, offers detailed molecular characteristics of athero-thrombosis.
In the field of atherosclerosis, prevention is equally important as treatment. The impact of eating habits in prophylaxis of many pathologies, including cardiovascular disease has been documented. Nutraceutical products, smoking cessation, physical activity, and many others they all have impact on atherosclerosis retention.
Then new pharmacological agents. Managing hypercholesterolemia with protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, shown great potential in efficient lipid lowering to achieve low-density lipoprotein-cholesterol (LDL-C) treatment goals, as well as reduction in cardiovascular mortality and morbidity. Some new noninsulin glucose-lowering drugs show improvement of cardiovascular outcomes in diabetic patients.
However, therapeutic goals accomplishment requires supervision. Arising number of data support that cardiovascular risk prediction can be improved with imaging modalities displaying atheroma: carotid plaque ultrasonography, coronary calcium score, intravascular ultrasonography, and optical coherent tomography or many others.
As atherosclerosis is a progressive disease, it comes the time for more radical management, including endovascular and surgical intervention. Both safety, and procedure optimization guarantee good outcome. There is field for new stent and equipment technologies, new surgical and endovascular techniques, supervision of endovascular procedures with IVUS, OCT, functional flow assessment or cell therapy.
From diagnosis to risk stratification, elaborated prevention models, finally to modern and optimized therapeutic intervention.
We welcome the submission of original research and review articles on the following topics:
- Molecular triggers of atherosclerosis
- Achieving goals in cardiovascular risk factors prevention and treatment
- Cardiovascular risk stratification and algorithms
- Imaging tools to control atherosclerosis reduction and progression
- Optimizing treatment for occlusive atherosclerotic lesions in coronary and extra coronary territories
Prof. Dr. Anna Kabłak-Ziembicka
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Cardiovascular risk
- Diagnosis and prevention
- Cell biology
- Pharmacological and non-pharmacological prevention
- Monitoring of goals
- Optimizing therapy
- Carotid intima-media
- Optical coherence tomography
- Carotid and peripheral interventions
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.